You are here: Home » International » News » Companies
Business Standard

Investigators find irregularities in Philip Morris e-cigarette experiments

The company has spent more than $3 billion developing new smoking platforms like iQOS

Reuters  |  Tokyo | Neuchatel, Switzerland 

The US Food and Drug Administration is weighing whether to approve a potentially path-breaking smoking device by Philip Morris International Inc. With a decision expected next year, former employees and contractors have described to Reuters a number of irregularities involving clinical trials that underpin the tobacco giant's application to the agency. By heating tobacco instead of burning it, the company says the device, known as iQOS, avoids subjecting smokers to the same levels of carcinogens and other toxic substances found in a regular cigarette. The company has spent more ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Thu, December 21 2017. 08:15 IST